Pentadecapeptide Arginate (PDA) – The Next-Gen Peptide for Connective Tissue and Inflammatory Balance

As legacy peptides like BPC-157 face increasing regulatory scrutiny, practitioners are turning to next-generation alternatives like Pentadecapeptide Arginate (PDA). This emerging peptide shows promise in supporting connective tissue repair, GI health, and inflammatory balance. Explore PDA’s mechanism of action, clinical applications, and flexible delivery options in this Tip Tuesday spotlight from the Advanced Practitioners Network.